Contact this trialFirst, we need to learn more about you.
Sphingosine-1-Phosphate Receptor Modulator
Ofatumumab + Siponimod vs Fingolimod for Pediatric Multiple Sclerosis
Recruiting1 awardPhase 3
Tampa, Florida
This trial tests three medications in children and teens with multiple sclerosis to find effective treatments. The drugs work by reducing harmful immune cells or preventing them from attacking the nervous system.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.